Nashville-based HCA Healthcare is one of the nation's leading providers of healthcare services comprising more than 2,000 sites of care, including 187 hospitals, surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 21 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44 percent. HCA Healthcare is a learning health system that uses its more than 35 million annual patient encounters to advance science, improve patient care and save lives.

Company profile
Ticker
HCA
Exchange
Website
CEO
Samuel Hazen
Employees
Location
Fiscal year end
Industry (SIC)
Former names
COLUMBIA HCA HEALTHCARE CORP, COLUMBIA HCA HEALTHCARE CORP/, COLUMBIA HEALTHCARE CORP, HCA Holdings, Inc., HCA INC/TN, HCA THE HEALTHCARE CO, HCA-THE HEALTHCARE CO
SEC CIK
Corporate docs
Subsidiaries
CareOne Home Health Services, Inc. • Four Rivers Medical Center PHO, Inc. • Selma Medical Center Hospital, Inc. • Alaska Regional Medical Group, LLC • Alaska Spine Center, LLC • Anchorage Surgicenter, LLC • Chugach PT, Inc. • Columbia Behavioral Healthcare, Inc. • SLS Mountain Division, LLC • Surgicare of Anchorage, LLC ...
IRS number
273865930
HCA stock data
Analyst ratings and price targets
Latest filings (excl ownership)
ARS
2022 FY
Annual report to shareholders
10 Mar 23
DEFA14A
Additional proxy soliciting materials
10 Mar 23
DEF 14A
Definitive proxy
10 Mar 23
10-K
2022 FY
Annual report
17 Feb 23
8-K/A
Departure of Directors or Certain Officers
30 Jan 23
8-K
Hca Healthcare Reports Fourth Quarter 2022 Results
27 Jan 23
8-K
Entry into a Material Definitive Agreement
4 Jan 23
8-K
Amendments to Articles of Incorporation or Bylaws
19 Dec 22
10-Q
2022 Q3
Quarterly report
1 Nov 22
8-K
Hca Healthcare Announces Operational Reorganization
26 Oct 22
Transcripts
HCA
Earnings call transcript
2022 Q4
27 Jan 23
HCA
Earnings call transcript
2022 Q3
21 Oct 22
HCA
Earnings call transcript
2022 Q2
22 Jul 22
HCA
Earnings call transcript
2022 Q1
22 Apr 22
HCA
Earnings call transcript
2021 Q4
27 Jan 22
HCA
Earnings call transcript
2021 Q3
22 Oct 21
HCA
Earnings call transcript
2021 Q2
20 Jul 21
HCA
Earnings call transcript
2021 Q1
22 Apr 21
HCA
Earnings call transcript
2020 Q4
2 Feb 21
HCA
Earnings call transcript
2020 Q3
26 Oct 20
Latest ownership filings
Financial summary
Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 908.00 mm | 908.00 mm | 908.00 mm | 908.00 mm | 908.00 mm | 908.00 mm |
Cash burn (monthly) | 30.33 mm | 45.25 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 85.39 mm | 127.39 mm | n/a | n/a | n/a | n/a |
Cash remaining | 822.61 mm | 780.61 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | 27.1 | 17.3 | n/a | n/a | n/a | n/a |
Institutional ownership, Q4 2022
91.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 930 |
Opened positions | 172 |
Closed positions | 83 |
Increased positions | 274 |
Reduced positions | 360 |
13F shares | Current |
---|---|
Total value | 42.80 tn |
Total shares | 252.91 mm |
Total puts | 1.33 mm |
Total calls | 1.31 mm |
Total put/call ratio | 1.0 |
Largest owners | Shares | Value |
---|---|---|
Hercules Holding Ii | 68.91 mm | $0.00 |
Vanguard | 17.95 mm | $4.31 tn |
BLK Blackrock | 14.84 mm | $3.56 tn |
Wellington Management | 14.37 mm | $3.45 tn |
Sanders Capital | 10.74 mm | $2.58 tn |
STT State Street | 9.11 mm | $2.19 tn |
T. Rowe Price | 7.04 mm | $1.69 tn |
Harris Associates L P | 6.67 mm | $1.60 tn |
KKR Millennium Fund | 5.18 mm | $0.00 |
JPM JPMorgan Chase & Co. | 4.77 mm | $1.15 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Feb 23 | Erol R Akdamar | Common Stock | Payment of exercise | Dispose F | No | No | 262.84 | 3,110 | 817.43 k | 45,984 |
17 Feb 23 | Erol R Akdamar | Common Stock | Grant | Acquire A | No | No | 0 | 9,300 | 0.00 | 49,094 |
17 Feb 23 | Jennifer Berres | Common Stock | Payment of exercise | Dispose F | No | No | 262.84 | 2,441 | 641.59 k | 12,551 |
17 Feb 23 | Jennifer Berres | Common Stock | Grant | Acquire A | No | No | 0 | 7,600 | 0.00 | 14,992 |
17 Feb 23 | Phillip G Billington | Common Stock | Payment of exercise | Dispose F | No | No | 262.84 | 1,247 | 327.76 k | 43,965.106 |
17 Feb 23 | Phillip G Billington | Common Stock | Grant | Acquire A | No | No | 0 | 4,560 | 0.00 | 45,212.106 |
17 Feb 23 | Michael S. Cuffe | Common Stock | Payment of exercise | Dispose F | No | No | 262.84 | 4,232 | 1.11 mm | 28,750.554 |
17 Feb 23 | Michael S. Cuffe | Common Stock | Grant | Acquire A | No | No | 0 | 12,160 | 0.00 | 32,982.554 |
17 Feb 23 | Jeffrey E. Cohen | Common Stock | Payment of exercise | Dispose F | No | No | 262.84 | 1,652 | 434.21 k | 5,914 |
17 Feb 23 | Jeffrey E. Cohen | Common Stock | Grant | Acquire A | No | No | 0 | 4,560 | 0.00 | 7,566 |
News
RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $283 Price Target
16 Mar 23
Analyst Expectations for HCA Healthcare's Future
13 Mar 23
Stephens & Co. Reiterates Overweight on HCA Healthcare, Maintains $283 Price Target
13 Mar 23
JP Morgan Maintains Overweight on HCA Healthcare, Raises Price Target to $257
23 Feb 23
Stephens & Co. Maintains Overweight on HCA Healthcare, Raises Price Target to $283
22 Feb 23
Press releases
HCA Healthcare Releases 2023 Annual Impact Report
23 Mar 23
HCA Healthcare Named as One of the 2023 World's Most Ethical Companies®
13 Mar 23
HCA Healthcare and The HCA Healthcare Foundation Announce $44 Million in Contributions to Community Organizations In 2022
23 Feb 23
HCA Healthcare, Inc. to Present at March Healthcare Conferences
9 Feb 23
HCA Healthcare Reports Fourth Quarter 2022 Results and Provides 2023 Guidance
27 Jan 23